NovaBay Pharmaceuticals to Hold First Quarter 2022 Conference Call on May 12
May 05 2022 - 6:50AM
Business Wire
NovaBay® Pharmaceuticals, Inc. (NYSE American: NBY) announces
that it will report financial results for the three months ended
March 31, 2022 after market close on Thursday, May 12, 2022 and
will hold an investment community conference call that day
beginning at 4:30 p.m. Eastern time.
Date/Time:
Thursday, May 12, 4:30 p.m. ET / 1:30 p.m.
PT
Pre-Registration:
Participants can pre-register for the
conference call here:
Callers who pre-register will be given a
conference passcode and unique PIN to gain immediate access to the
call and bypass the live operator. Participants may pre-register at
any time, including up to and after the call start time.
Dial In:
Those who choose not to pre-register can
access the live conference call by dialing the following and
requesting the NovaBay Pharmaceuticals call:
866-777-2509 from within the U.S.
412-317-5413 from outside the U.S.
The live webcast of the conference call also will be available
at http://novabay.com/investors/events. A replay of the call will
be available beginning two hours after its completion through June
2, 2022 by dialing 877-344-7529 from within the U.S., 855-669-9658
from Canada or 412-317-0088 from outside the U.S., and entering
conference ID 9711049. The webcast will also be archived at
http://novabay.com/investors/events.
About NovaBay Pharmaceuticals, Inc:
NovaBay Pharmaceuticals, Inc. is a pharmaceutical company that
develops and sells scientifically created and clinically proven
consumer products for the eyecare and skincare markets. Avenova® is
the most prescribed antimicrobial lid and lash spray in the eyecare
market. In November 2021, NovaBay acquired DERMAdoctor, LLC, a
company offering more than 30 dermatologist-developed skincare
products sold through traditional domestic retailers, digital
beauty channels and international distributors.
Socialize and Stay Informed on
NovaBay’s
Progress
Like us on Facebook Follow us on Twitter Connect with NovaBay on
LinkedIn Visit NovaBay’s Website
Avenova Purchasing
Information
For NovaBay Avenova purchasing information: Please call
800-890-0329 or email sales@avenova.com Avenova.com
DERMAdoctor Purchasing
Information
For DERMAdoctor purchasing information: Please call 877-337-6237
or email service@dermadoctor.com DERMAdoctor.com
View source
version on businesswire.com: https://www.businesswire.com/news/home/20220505005162/en/
NovaBay Contact Justin Hall
Chief Executive Officer and General Counsel 510-899-8800
jhall@novabay.com
Investor Contact LHA
Investor Relations Jody Cain 310-691-7100 jcain@lhai.com
NovaBay Pharmaceuticals (AMEX:NBY)
Historical Stock Chart
From Mar 2024 to Apr 2024
NovaBay Pharmaceuticals (AMEX:NBY)
Historical Stock Chart
From Apr 2023 to Apr 2024